Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tacrolimus

A macrolide immunosuppressant that blocks calcineurin in T lymphocytes, discovered in Japan in the 1980s and used since 1994 to prevent transplant rejection; as an ointment it also treats atopic dermatitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Its name comes from 'Tsukuba macrolide immunosuppressant': the bacterium that produces it, Streptomyces tsukubensis, was isolated in 1984 from a soil sample taken on Mount Tsukuba, Japan.

TacrolimusGo to the active ingredient →
TacrolimusActive ingredientTacrolimusCat. No. P-T004-001CAS 104987-11-3

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.